Clear, sourced knowledge about peptides.Peptides, with sources

See all sourcesSources

Search peptides, guides and rules

Semax

Early studies in humans

Skin, ageing and wellbeing
Written by The Peptideguiden editors. Sources checked 25 October 2026. Last updated 29 October 2026.

A student reads with focus at a table
Research areaMemory and focus
Contents
  1. In short
  2. What is Semax?
  3. What does the research say about Semax?
  4. Questions and answers
  5. Norwegian vendor feedback
  6. Sources (8)

In short

  • Semax is a synthetic peptide based on part of the stress hormone ACTH. It was developed in Russia.
  • In Russian studies of patients after stroke, recovery was somewhat faster with Semax, and daily functions improved.
  • In rats, Semax raised the level of BDNF, a substance that matters for nerve cells, and protected nerve tissue when blood supply was reduced.
  • In healthy adults, Semax nasal drops changed activity in a resting network in the brain.

Fact box

Type
Research compound
Research
Early human studies
Sequence
Met-Glu-His-Phe-Pro-Gly-Pro
Other names
Семакс, ACTH(4-7)-PGP

What is Semax?

Semax is a peptide of seven amino acids, made from part of the hormone ACTH. In the studies it is given as nasal drops. It has drawn interest for possible better focus and memory.

Semax is a synthetic version of part of ACTH, a hormone the body releases under stress. In rats, Semax nasal drops raised the level of BDNF, a substance that matters for nerve cells, in parts of the brain.[1]

Russian researchers write that Semax is used in clinical practice in Russia for serious problems with blood flow in the brain.[2]

The amino acid sequence in the fact box comes from PubChem.[3]

What does the research say about Semax?

There are a few Russian studies of patients after stroke, with somewhat faster recovery, and one study of brain activity in healthy adults. In animals, Semax protected nerve tissue.

What does the research say about Semax?
UseStudiesResearch
Stroke2 studies · Controlled study · n = 220Early human studies
Brain activity in healthy adults1 study · Controlled study · n = 24Early human studies
Nerve protection2 studies · Animal study · AnimalsLab and animal studies

RCT means randomised controlled trial. How to read a study

Stroke

In a Russian study from 1997, 30 patients with acute stroke received Semax on top of usual treatment. They were compared with 80 patients who had usual treatment only. The researchers reported somewhat faster recovery of movement and other functions.[4]

A study from 2018 followed 110 patients in rehabilitation after stroke. Those who received Semax had higher levels of BDNF in the blood and better recovery of daily functions.[5]

Brain activity in healthy adults

A study with 24 healthy adults measured brain activity with MRI right after nasal drops with Semax or placebo. The researchers saw changes in a network in the brain that is active at rest.[6]

Nerve protection

In rats, Semax raised the level of BDNF in the brain.[1] In a rat model with reduced blood supply to the brain, Semax gave less damage to nerve tissue.[2]

Questions and answers about Semax

Does Semax improve focus?

In healthy adults, Semax changed activity in a resting network in the brain. Studies of focus and memory are the next step.

What is Semax used for?

In Russia it is used for serious problems with blood flow in the brain, such as after a stroke.

How is Semax taken?

In the studies, Semax was given as nasal drops.

What people say about Norwegian vendors

Read a detailed comparison

Explore feedback on ordering, delivery and customer support from Norwegian peptide vendors. For education only, with no promotion or recommendations.

Sources

  1. [1]

    Dolotov OV, et al. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. J Neurochem. 2006.

    PMID 16635254DOIAnimal study

  2. [2]

    Stavchansky VV, et al. The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study. J Mol Neurosci. 2011.

    PMID 20617398DOIAnimal study

  3. [3]

    Semax (CID 9811102). PubChem, National Library of Medicine. 2026.

    PubChem, National Library of MedicineOther

  4. [4]

    Gusev EI, Skvortsova VI, Miasoedov NF, et al. Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study). In Russian. Zh Nevrol Psikhiatr Im S S Korsakova. 1997.

    PMID 11517472Controlled study · n = 110

  5. [5]

    Gusev EI, et al. The efficacy of semax in the treatment of patients at different stages of ischemic stroke. In Russian. Zh Nevrol Psikhiatr Im S S Korsakova. 2018.

    PMID 29798983DOIControlled study · n = 110

  6. [6]

    Lebedeva IS, Panikratova YR, Sokolov OY, et al. Effects of Semax on the Default Mode Network of the Brain. Bull Exp Biol Med. 2018.

    PMID 30225715DOIControlled study · n = 24

  7. [7]

    The 2026 Prohibited List. International Standard. World Anti-Doping Agency (WADA). 2026.

    World Anti-Doping Agency (WADA)Official source

  8. [8]

    Seks peptider på dopinglisten av hensyn til folkehelsen. Direktoratet for medisinske produkter (DMP). 2026.

    Direktoratet for medisinske produkter (DMP)Official source

Change log

  • 2026-10-29 English version published, written from the Norwegian page. All sources are checked against PubMed, DOI or the source website.